KAPLAN GILLA
SEC CIK 1247024 · EDGAR
BoughtSold
Most active insiders at AVTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sullivan Christopher Ryan | CFO | — | $3.72M |
| 2 | Doyle Mittie | Chief Medical Off | — | $2.98M |
| 3 | VARKI PAUL | CLO | — | $1.51M |
| 4 | Goldman Jonathan | Dir | — | $163.0K |
| 5 | Chan Mitchell | Dir | — | $72.5K |
| 6 | Riley Jennifer | Chief Strategy Off | — | $52.0K |
| 7 | Truex Samantha | Dir | — | — |
| 8 | KANTOFF AARON | Dir | — | — |
| 9 | NEIL GARRY ARTHUR | CEO, Dir | — | — |
| 10 | KAPLAN GILLA | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-31 | 2026-03-28 | AVTX | Avalo Therapeutics, Inc. | KAPLAN GILLA | Dir | M - OptEx | — | +3,166 | 6,333 | +100% | — |
| D | 2026-03-27 | 2026-03-25 | TYRA | Tyra Biosciences, Inc. | KAPLAN GILLA | Dir | S - Sale+OE | $36.97 | -14.3K | 28.2K | -34% | -$528.5K |
| DM | 2026-03-27 | 2026-03-25+ | TYRA | Tyra Biosciences, Inc. | KAPLAN GILLA | Dir | M - OptEx | $2.25 | -38.9K | 81.4K | -32% | -$87.5K |
| D | 2026-03-27 | 2026-03-26 | TYRA | Tyra Biosciences, Inc. | KAPLAN GILLA | Dir | D - Sale to Iss | $37.75 | -53.2K | 28.2K | -65% | -$2.01M |
| M | 2025-06-20 | 2025-06-17+ | TYRA | Tyra Biosciences, Inc. | KAPLAN GILLA | Dir | S - Sale | $9.78 | -9,578 | 37.8K | -20% | -$93.7K |
| M | 2025-06-16 | 2025-06-12+ | TYRA | Tyra Biosciences, Inc. | KAPLAN GILLA | Dir | S - Sale | $10.32 | -51.8K | 37.8K | -58% | -$534.7K |
| D | 2025-04-01 | 2025-03-28 | AVTX | Avalo Therapeutics, Inc. | KAPLAN GILLA | Dir | M - OptEx | — | +3,167 | 3,167 | New | — |
| D | 2024-06-18 | 2024-06-13 | TYRA | Tyra Biosciences, Inc. | KAPLAN GILLA | Dir | M - OptEx | $0.61 | +61.4K | 89.6K | +217% | +$37.4K |
Purchase Sale Sale after option exercise All abbreviations